Blood-Borne Viruses: Hepatitis A to G

Lutz Gürtler

doi:10.1055/s-2002-30193

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2002; 28(S1): 031-036
DOI: 10.1055/s-2002-30193

Blood-Borne Viruses: Hepatitis A to G

Lutz Gürtler

Institute for Medical Microbiology, University of Greifswald, Greifswald, Germany

Abstract

Full Text

References

REFERENCES

1 Hollinger F B, Kahn N C, Oefinger P E. Posttransfusion hepatitis type A. JAMA . 1983; 250 2313-2317
2 Franci P, London W T, Wong D C. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serological responses measured with first- and second-generation assays and relationship to HCV viremia. J Infect Dis . 1992; 165 1006-1011
3 Mannucci P M. Outbreak of hepatitis A among Italian patients with haemophilia. Lancet . 1992; 339 819
4 Daikos G L, Lai S, Fischl M A. Hepatitis C virus infection in a sexually active inner city population: the potential of heterosexual transmission. Infection . 1994; 22 72-76
5 Rockstroh J K, Ewig S, Bauer T. Male-to-female transmission of HIV in a cohort of hemophiliacs-frequency, risk factors and effects of sexual counseling. Infection . 1995; 23 29-32
6 Glück D, Elbert G, Dengler T. HIV-Lookback-Studie der DRK-Blutspendedienste in der BRD. Infusionsther Transfusionsmed . 1994; 21 368-375
7 Zeiler T, Kretschmer V, Sibrowski W. Eine retrospektive Untersuchung zur Praxis der Look-back-Verfahren, zur Inzidenz HIV 1/2-positiver Blutspender und zum Risiko der transfusionsassoziierten HIV-Infektion bei den staatlich-kommunalen Blutspendediensten in Deutschland. Infusionsther Transfusionsmed . 1994; 21 362-367
8 Manson-Bahr P EC, Bell D R. Manson's Tropical Medicine. London: Bailliere Tindall 1991
9 Schramm W, Roggendorf M, Rommel F. Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs. Blut . 1989; 59 390-392
10 Carman W F, Korula J, Wallace L. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HbsAgELISA. Lancet . 1995; 345 1406-1407
11 Van der Poel L C, Cuypers T, Reesink H W. Hepatitis C virus six years on. Lancet . 1994; 344 1475-1479
12 Hu D, Dondero T J, Rayfield M A. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research and prevention. JAMA . 1996; 275 210-216
13 Ticehurst J, Feinstone S M, Chestnut T. Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization. J Clin Microbiol . 1987; 25 1822-1829
14 Kaneko S, Miller R H, Feinstone S M. Detection of serum hepatitis B DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci USA . 1989; 86 312-316
15 Jilg W, Schmidt M, Deinhardt F. Prolonged immunity after late booster doses of hepatitis B vaccine. J Infect Dis . 1988; 157 1267-1269
16 Uyttendale S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third-generation screening and confirmatory assay for HCV antibodies. Vox Sang . 1994; 66 122-129
17 Goldsmith R, Yarbough P O, Reyes G R. Enzyme linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet . 1992; 339 328-332
18 Zuckerman A J. Alphabet of hepatitis viruses. Lancet . 1996; 347 558-559
19 Horowitz B, Prince A M, Hamman J, Watklevicz C. Viral safety of solvent/detergent treated blood products. Blood Coagul Fibrinolysis . 1994; 5(Suppl 3) S21-S28
20 Buckley R, Schiff R I. The use of intravenous immune globulins in immunodeficiency diseases. N Engl J Med . 1991; 325 110-117
21 AuBuchon J P, Birkmeyer J D. Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero risk blood supply. JAMA . 1994; 272 1210-1214
22 Loutan L, Bovier P, Althaus B, Glück R. Inactivated virosome hepatitis A vaccine. Lancet . 1994; 343 322-324
23 Whittle H C, Maine N, Pilkington J. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet . 1995; 345 1089-1092
24 Ohto H, Terazawa S, Sasaki N. Transmission of hepatitis C virus from mothers to infants. N Engl J Med . 1994; 330 744-750
25 Shavrina L V, Innis B L, Shrestha P, Ticehurst J, Baze W B. Virus like particles in the liver of a patient with fulminant hepatitis and antibody to hepatitis E virus. J Med Virol . 1990; 31 229-233
26 Hyams K C, Purdy M A, Kaur M. Acute sporadic hepatitis E in Sudanese children: analysis based on a new western blot assay. J Infect Dis . 1992; 165 1001-1005
27 Anderson M J, Higgins P G, Davis L R. Experimental parvoviral infection in humans. J Infec Dis . 1985; 152 257-265
28 Schwarz T F, Jäger G. Hämatologische Bedeutung der Parvovirus-B-19-Infektion. Dtsch Med Wochenschr . 1993; 118 873-878
29 Wolff C, Skourtopoulos M, Hörnschemeyer D. Significance of human cytomegalovirus DNA detection in immunocompromised heart transplant patients. Transplantation . 1996; 61 750-751
30 Hitchcock M JM, Jaffe H S, Martin J C, Stagg R J. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chem Chemother . 1996; 7 115-127
31 Lasmézas C I, Deslys J P, Robain O. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science . 1997; 275 402-405
32 Esmonde T GF, Will R G, Slattery J M. Creutzfeldt-Jakob disease and blood transfusion. Lancet . 1993; 341 205-207
33 Heye N, Hensen S, Müller N. Creutzfeldt-Jakob disease and blood transfusion. Lancet . 1994; 343 298-299
34 Monath T P, Heinz F X. Flaviviruses. In: Fileds BN, Knipe DM, Howley PM, eds. Virology, 3rd ed< 1996: 961-1034